Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
Abstract
A next-generation, broad-spectrum, orally efficacious influenza A and B virus inhibitor is associated with a high genetic resistance barrier.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 23, 2019
- Source ID
- 10.1126/scitranslmed.aax5866
Entities
People
- Alec H Barrena
- Alexander A. Kolykhalov
- Alexander L. Greninger
- Deborah G. Mitchell
- George R. Painter
- Gregory R Bluemling
- Jeong-Joong Yoon
- Mart Toots
- Michael G. Natchus
- Michael Hart
- Negar Makhsous
- Prabhakar G. Reddy
- Richard K Plemper
- Robert M. Cox
- Roland Plesker
- Ryan C Shean
- Zachary M Sticher
Organizations
- Defense Threat Reduction Agency
- Emory University
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Georgia State University
- National Institute of Allergy and Infectious Diseases
- Paul Ehrlich Institute
- University of Washington